Acer Therapeutics Inc. - FORM 10-K - EX-23 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM MALONEBAILEY, LLP - March 5, 2010

Attached files

file filename
10-K - FORM 10-K - Acer Therapeutics Inc.d10k.htm
EX-31.1 - CERTIFICATION OF CEO AND CFO SECTION 302 - Acer Therapeutics Inc.dex311.htm
EX-10.9 - EMPLOYMENT AGREEMENT - Acer Therapeutics Inc.dex109.htm
EX-32.1 - CERTIFICATION OF CEO AND CFO SECTION 906 - Acer Therapeutics Inc.dex321.htm
EX-10.15 - CERTIFICATE OF AMENDMENTS TO JUNE 2004 COMPENSATORY STOCK OPTION PLAN - Acer Therapeutics Inc.dex1015.htm

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement on Forms S-3 (No. 333-153501, 333-162397 and 333-163108), and Form S-8 (No. 139196) pertaining to the Opexa Therapeutics, Inc. June 2004 Compensatory Stock Option Plan, of our report dated March 4, 2010 with respect to the audited financial statements of Opexa Therapeutics, Inc. for the years ended December 31, 2009 and 2008.

 

/s/    MaloneBailey, LLP        
MaloneBailey, LLP
www.malone-bailey.com
Houston, Texas
March 4, 2010

Acer Therapeutics Inc. Reports